TY - JOUR
T1 - Double-blind evaluation of etodolac (200 mg, 400 mg) compared with zomepirac (100 mg) and placebo on third molar extraction pain
AU - Scott, Richard
AU - Ellis, Edward
AU - Upton, L. George
PY - 1986/12
Y1 - 1986/12
N2 - This controlled, single dose study has demonstrated that compared with placebo, substantial analgesia is obtained with 200 and 400 mg doses of etodolac. The analgesic effects of both doses of etodolac were not notably different from each other or significantly different from zomepirac, a proven analgesic. With respect to safety, both doses of etodolac were well tolerated, with no reports of serious or dose related adverse side effects.
AB - This controlled, single dose study has demonstrated that compared with placebo, substantial analgesia is obtained with 200 and 400 mg doses of etodolac. The analgesic effects of both doses of etodolac were not notably different from each other or significantly different from zomepirac, a proven analgesic. With respect to safety, both doses of etodolac were well tolerated, with no reports of serious or dose related adverse side effects.
UR - http://www.scopus.com/inward/record.url?scp=0022992204&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022992204&partnerID=8YFLogxK
U2 - 10.1016/0030-4220(86)90255-0
DO - 10.1016/0030-4220(86)90255-0
M3 - Article
C2 - 2948143
AN - SCOPUS:0022992204
SN - 0030-4220
VL - 62
SP - 638
EP - 642
JO - Oral Surgery, Oral Medicine, Oral Pathology
JF - Oral Surgery, Oral Medicine, Oral Pathology
IS - 6
ER -